Free Trial

Avadel Pharmaceuticals (AVDL) SEC Filings & 10K Form

Avadel Pharmaceuticals logo
$9.61 -0.16 (-1.64%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$9.46 -0.15 (-1.51%)
As of 07/11/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avadel Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/30/2025
9:56 AM
ASL Strategic Value Fund, LP (Filed by)
Avadel Pharmaceuticals (Subject)
Form PX14A6G
06/18/2025
6:01 AM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
06/18/2025
6:03 AM
Avadel Pharmaceuticals (Filer)
Form DEFA14A
06/18/2025
6:05 AM
Avadel Pharmaceuticals (Filer)
Form ARS
06/05/2025
6:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
11:00 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/13/2025
5:00 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/13/2025
5:01 PM
Avadel Pharmaceuticals (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:22 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
8:20 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
1:59 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
2:01 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:45 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
8:16 AM
Avadel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:09 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
10:55 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
01/28/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:22 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:24 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:18 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
3:15 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:20 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:13 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
5:14 PM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
6:00 AM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:02 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:50 AM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
5:10 AM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
4:58 PM
Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G/A
11/12/2024
6:06 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
9:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:18 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:01 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
8:25 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:12 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

08/01/2024
3:31 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:32 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:35 PM
Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:36 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:37 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:38 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners